Treatment of adverse perinatal outcome in inherited thrombophilias: A clinical study

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 1, 2011, Pages 14-18

  Kosar, Ali ^b   Kasapoglu, Benan ^a   Kalyoncu, Senol ^c   Turan, Hakan ^d   Balcik, Ozlem S ^b   Gümüs, Emine I ^b  

^a Internal Medicine Department   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

^c Zekai Tahir Burak Training and Research Hospital   (Turkey)

^d Ankara Oncology Research and Training Hospital   (Turkey)

Author keywords

acetylsalicylic acid; heparin; inherited thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; FOLIC ACID; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; BIRTH RATE; CLINICAL STUDY; FEMALE; FETUS WASTAGE; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; THROMBOPHILIA;

ADULT; ANTICOAGULANTS; ASPIRIN; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHILIA; YOUNG ADULT;

EID: 78650779680     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834013f2     Document Type: Article

References (17)

1. Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U. Williams hematology, 6th ed. New York: McGraw Hill Professional; 2001. Part X: Pp. 1697-1743.
2. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353:1258-1265.
3. Stella CL, Sibai BM. Thrombophilia and adverse maternal-perinatal outcome. Clin Obstet Gynecol 2006; 49:850-860.
4. Pabinger I, Vormittag R. Thrombophilia and pregnancy outcomes. J Thromb Haemost 2005; 3:1603-1610.
5. Scothie J, Fritz MA. Early pregnancy loss. Postgrad Obstet Gynecol 2006; 18:1-8.
6. Carrington B, Sacks G, Regan L. Recurrent miscarriage: Pathophysiology and outcome. Curr Opin Obstet Gynecol 2005; 17:519-527.
7. Redline RW. Thrombophilia and placental pathology. Clin Obstet Gynecol 2006; 49:885-894.
8. Mahieu B, Jacobs N, Mahieu S, Naelaerts K, Vertessen F, Weyler J, et al. Haemostatic changes and acquired activated protein C resistance in normal pregnancy. Blood Coagul Fibrinolysis 2007; 18:685-688.
9. Scifres C. Venous thromboembolism in pregnancy. Postgrad Obstet Gynecol 2006; 18:1-8.
10. Robertson L, Wu O, Langhorne P. Thrombophilia in pregnancy: A systematic review. Br J Haematol 2006; 132:171-196.
11. Paidos MJ, Ku DH, Ross JL. Inherited thrombophilias and adverse pregnancy outcome: Screening and management. Semin Perinatol 2005; 29:150-163.
12. Branch DW, Eller AG. Antiphospolipid syndrome and thrombosis. Clin Obstet Gynecol 2006; 49:861-871.
13. Gris JC, Lissalde-Lavigne G, Quere I, Dauzat M, Mares P. Prophylaxis and treatment of thrombophilia in pregnancy. Curr Opin Hematol 2006; 13:376-381.
14. Brunton LL. Goodman and Gilman's the pharmacological basis of therapeutics. In: Majerus PW, Tollefsen DM, editors. Blood coagulation and anticoagulant, thrombolytic, and antiplatelet drugs. New York: McGraw Hill; 2006. pp. 1467-1488.
15. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000; 83:693-697.
16. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 2003; 1:433-438.
17. Gonzalez-Herrera L, Castillo-Zapata I, Garcia-EscalanteG, Pinto-Escalante D. A1298C polymorphism of the MTHFR C677T gene and neural tube defects in the state of Yucatan, Mexico. Birth Defects Res A Clin Mol Teratol 2007; 79:622-626.